Supriya Lifescience Limited
Cohesion MK Best Ideas increased its stake in Supriya Lifescience Limited from 2.98% to 3.17%, acquiring 1,49,170 shares.
A pharmaceutical manufacturer engaged in the production of active pharmaceutical ingredients across diverse therapeutic segments including antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic, and anti-allergic formulations. The company operates integrated manufacturing facilities focused on API synthesis and development for both domestic and international markets. Supriya Lifescience maintains a broad product portfolio serving multiple therapeutic areas within the pharmaceutical industry.
Launched August 2020 by Cohesion Asset Management (Abu Dhabi) in partnership with Madhusudan Kela, "the King of the Multi-Bagger" who scaled Reliance MF's equity business from ~USD 20 m to ~USD 60 bn. Concentrated 20 to 25 stock portfolio that gives global investors access to Kela's high-conviction Indian equity picks.
